Safety and effectiveness of natalizumab re-dosing and treatment in the STRATA study

被引：0
|
作者：
Polman, Chris H. [1 ]
Goodman, Andrew [2 ]
Kappos, Ludwig [3 ]
Lublin, Fred [4 ]
O'Connor, Paul [5 ]
Rudick, Richard [6 ]
Jurgensen, Stephanie [7 ]
Lucas, Nisha [7 ]
Abdul-Ahad, Ayad [7 ]
Panzara, Michael [7 ]
机构：
[1] VU Med Ctr, Amsterdam, Netherlands
[2] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Mt Sinai Sch Med, New York, NY USA
[5] St Michaels Hosp, Div Neurol, Toronto, ON M5B 1W8, Canada
[6] Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44195 USA
[7] Biogen Idec Inc, Cambridge, England
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [1] The safety of TVSABRI® re-dosing and treatment (STRATA) study
    O'Connor, Paul W.
    Goodman, Andrew D.
    Kappos, Ludwig
    Lublin, Fred D.
    Polman, Chris H.
    Rudick, Richard
    Jurgensen, Stephanie
    Lucas, Nisha
    Abdul-Ahad, Ayad
    Panzara, Michael
    NEUROLOGY, 2008, 70 (11) : A104 - A105
  • [2] Safety of natalizumab upon re-dosing: preliminary results from the STRATA study
    O'Connor, P.
    Goodman, A.
    Kappos, L.
    Lublin, F.
    Miller, D.
    Polman, C.
    Rudick, R.
    Lucas, N.
    Kim, R.
    Abdul-Ahad, A.
    Panzana, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S168 - S169
  • [3] Efficacy and safety of natalizumab re-dosing and treatment in patients from Poland
    Selmaj, K.
    Czlonkowska, A.
    Drozdowski, W.
    Fryze, W.
    Kochanowicz, J.
    Kwiecinski, H.
    Maciejek, Z.
    Stelmasiak, Z.
    Szczudlik, A.
    Wajgt, A.
    Forrestal, F.
    Buffels, R.
    JOURNAL OF NEUROLOGY, 2011, 258 : 256 - 257
  • [4] Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
    Csepany Tuende
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2014, 67 (7-8): : 277 - 279
  • [5] Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
    O'Connor, Paul
    Goodman, Andrew
    Kappos, Ludwig
    Lublin, Fred
    Polman, Chris
    Rudick, Richard A.
    Hauswirth, Kathy
    Cristiano, Lynda M.
    Forrestal, Fiona
    Duda, Petra
    NEUROLOGY, 2014, 83 (01) : 78 - 86
  • [6] Efficacy and Safety of Natalizumab in the STRATA Study
    O'Connor, Paul
    Polman, Chris
    Goodman, Andrew
    Kappos, Ludwig
    Lublin, Fred
    Rudick, Richard
    Jurgensen, Stephanie
    Paes, Dominick
    Lucas, Nisha
    Panzara, Michael
    NEUROLOGY, 2009, 72 (11) : A312 - A313
  • [7] Is re-dosing of vancomycin necessary?
    Khan, JH
    Davis, EA
    ANNALS OF THORACIC SURGERY, 2006, 81 (02): : 789 - 789
  • [8] Efficacy and safety of natalizumab in the STRATA study
    O'Connor, P. W.
    Polman, C. H.
    Goodman, A. D.
    Kappos, L.
    Lublin, F. D.
    Rudick, R. A.
    Jurgensen, S.
    Paes, D.
    Forrestal, F.
    Hotermans, C.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S241 - S241
  • [9] Efficacy and Safety of Natalizumab in the STRATA Study
    Polman, Chris
    Goodman, Andrew
    Kappos, Ludwig
    Lublin, Fred
    O'Connor, Paul
    Rudick, Richard
    Jurgensen, Stephanie
    Paes, Dominick
    Forrestal, Fiona
    Hotermans, Christophe
    NEUROLOGY, 2010, 74 (09) : A553 - A553
  • [10] Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing"
    Sehr, Tony
    Proschmann, Undine
    Thomas, Katja
    Ziemssen, Tjalf
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (06) : 820 - 822
12345